Effects of montelukast on the healing of ischemic colon anastomoses
Erişim
info:eu-repo/semantics/embargoedAccessTarih
2013Yazar
Çelik, AtillaErgun, Ersin
Köksal, Neşet
Çelik, Aysun Şimşek
Altınlı, Ediz
Uzun, Mehmet Ali
Kemik, Ahu
Üst veri
Tüm öğe kaydını gösterKünye
https://www.clinicalkey.com/#!/ContentPlayerCtrl/doPlayContent/1-s2.0-S0002961013003048Celik A, Ergun E, Koksal N, Celik AS, Altinli E, Uzun MA, Eroglu E, Kemik A. Effects of montelukast on the healing of ischemic colon anastomoses. American Journal of Surgery. 2013; 206(4): 502-8. doi: 10.1016/j.amjsurg.2013.03.003.
Özet
BACKGROUND: The aim of this study was to examine whether treatment with montelukast, a selective
leukotriene antagonist, would affect anastomotic healing in a reperfused colon rat model with remote
ischemia/reperfusion injury.
METHODS: Rats (n 5 12 per group) were intraperitoneally administered normal saline or 10 mg/kg
montelukast sodium 60 minutes before and for 5 days after surgery. Ischemia was induced for 45 minutes
through superior mesenteric artery occlusion. A left colon anastomosis was made. Blood and perianastomotic
tissue samples were obtained on postoperative day 5.
RESULTS: Mean anastomotic bursting pressures of the control and montelukast groups were 159.17
6 29.99 and 216.67 6 26.40, respectively (P , .001). Compared with saline, montelukast treatment
increased the mean tissue hydroxyproline level (2.46 6 .30 vs 3.61 6 .33 mmol/L) and decreased tissue
caspase-3 activity (36.06 6 5.72 vs 21.78 6 3.87) and malondialdehyde levels (3.43 6 .34 vs 2.29 6
.34 nmol/g) (P , .001 for all). Other plasma markers of injury also showed differences.
CONCLUSIONS: Montelukast prevented ischemia/reperfusion-induced damage in a rat model of
colonic anastomotic wound healing.
Kaynak
American Journal of SurgeryCilt
206Sayı
4Bağlantı
https://www.clinicalkey.com/#!/ContentPlayerCtrl/doPlayContent/1-s2.0-S0002961013003048https://hdl.handle.net/11446/392